60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3M; returns 1 day -0.7%, 1 week +1.7%, 1 year -85.0%.

60 Degrees Pharmaceuticals Inc. (SXTP) is a pharmaceutical company established in 2010, specializing in developing and commercializing new medicines for treating and preventing vector-borne and infectious diseases. Their lead product, ARAKODA® (tafenoquine), received FDA approval in 2018 for malaria prevention and is commercially available in the U.S. and Australia.

Groups SXTP belongs to

• Recent Reverse Splits
• Pharmaceuticals
• Infectious Diseases
• Biotechnology
• Healthcare
• Commercial Stage
• Life Sciences
• Antivirals

SXTP financial model: income statement, cash flow and balance sheet